Modeling Sitagliptin Effect on Dipeptidyl Peptidase IV (DPP4/CD26) Activity in Adults with Hematological Malignancies After Umbilical Cord Blood (UCB) Hematopoietic Stem Cell Transplant (HSCT)

被引：0

|

作者：

de Mendizabal, Nieves Velez ^{[1
,2
]}

Strother, Robert M. ^{[3
]}

Messina-Graham, Steven

Farag, Sherif S. ^{[1
]}

Broxmeyer, Hal ^{[4
]}

Bies, Robert R. ^{[1
,2
]}

机构：

[1] Indiana Univ Sch Med, Indianapolis, IN 46202 USA

[2] Indiana Clin & Translat Sci Inst CTSI, Indianapolis, IN USA

[3] Christchurch Hosp, Christchurch, New Zealand

[4] Indiana Univ Purdue Univ, Indianapolis, IN 46202 USA

来源：

JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS | 2013年 / 40卷

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：S15 / S15

页数：1

相关论文

共 3 条

[1] Modelling the Sitagliptin Effect on Dipeptidyl Peptidase-4 Activity in Adults with Haematological Malignancies After Umbilical Cord Blood Haematopoietic Cell Transplantation
de Mendizabal, Nieves Velez
Strother, Robert M.
Farag, Sherif S.
Broxmeyer, Hal E.
Messina-Graham, Steven
Chitnis, Shripad D.
Bies, Robert R.
CLINICAL PHARMACOKINETICS, 2014, 53 (03) : 247 - 259
[2] Modelling the Sitagliptin Effect on Dipeptidyl Peptidase-4 Activity in Adults with Haematological Malignancies After Umbilical Cord Blood Haematopoietic Cell Transplantation
Nieves Vélez de Mendizábal
Robert M. Strother
Sherif S. Farag
Hal E. Broxmeyer
Steven Messina-Graham
Shripad D. Chitnis
Robert R. Bies
Clinical Pharmacokinetics, 2014, 53 : 247 - 259
[3] A Prospective Phase II Clinical Trial of CD26/Dipeptidyl Peptidase (DPP)-IV Inhibition for Prevention of Acute Graft Versus Host Disease (aGVHD) Following Myeloablative Allogeneic Peripheral Blood Stem Cell (PBSC) Transplantation.
Farag, Sherif S.
Abu Zaid, Mohammad
Nelson, Robert P.
Schwartz, Jennifer E.
Thakrar, Teresa C.
Huntley, Carol
Blakley, Anne J.
Abonour, Rafat
Robertson, Michael J.
Zhang, Shuhong
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : S27 - S28